Adaptive Biotechnologies (ADPT) Short Interest Ratio & Short Volume $5.82 +0.19 (+3.37%) (As of 11/8/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Adaptive Biotechnologies Short Interest DataAdaptive Biotechnologies (ADPT) has a short interest of 9.48 million shares. This marks a -4.34% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 1.41 million shares to cover all short positions.Current Short Interest9,480,000 sharesPrevious Short Interest9,910,000 sharesChange Vs. Previous Month-4.34%Dollar Volume Sold Short$47.12 millionShort Interest Ratio8.2 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares147,470,000 sharesPercentage of Shares Shorted6.43%Today's Trading Volume1,382,653 sharesAverage Trading Volume1,409,130 sharesToday's Volume Vs. Average98% Short Selling Adaptive Biotechnologies? Sign up to receive the latest short interest report for Adaptive Biotechnologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADPT Short Interest Over TimeADPT Days to Cover Over TimeADPT Percentage of Float Shorted Over Time Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Adaptive Biotechnologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20249,480,000 shares $47.12 million -4.3%N/A8.2 $4.97 9/30/20249,910,000 shares $50.74 million +2.9%N/A8.1 $5.12 9/15/20249,630,000 shares $44.39 million -0.8%N/A7.6 $4.61 8/31/20249,710,000 shares $45.64 million +0.5%N/A7.4 $4.70 8/15/20249,660,000 shares $47.62 million -11.8%N/A6.6 $4.93 7/31/202410,950,000 shares $49.82 million -8.1%N/A7.3 $4.55 Get the Latest News and Ratings for ADPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 7/15/202411,910,000 shares $48.00 million -1.9%N/A7.9 $4.03 6/30/202412,140,000 shares $43.95 million -7.0%N/A7.4 $3.62 6/15/202413,050,000 shares $40.85 million -2.5%N/A7.6 $3.13 5/31/202413,380,000 shares $46.16 million +1.8%N/A7.8 $3.45 5/15/202413,140,000 shares $51.25 million +9.1%N/A7.9 $3.90 4/30/202412,040,000 shares $31.54 million +20.3%N/A7 $2.62 4/15/202410,010,000 shares $29.13 million +10.0%7.2%6 $2.91 3/31/20249,100,000 shares $29.21 million +7.6%6.6%6.1 $3.21 3/15/20248,460,000 shares $27.41 million -3.5%6.1%5.9 $3.24 2/29/20248,770,000 shares $36.04 million -4.6%N/A5.9 $4.11 2/15/20249,190,000 shares $36.39 million +4.3%N/A6.6 $3.96 1/31/20248,810,000 shares $32.33 million +0.6%N/A5.9 $3.67 1/15/20248,760,000 shares $38.54 million -7.4%N/A5.6 $4.40 12/31/20239,460,000 shares $46.35 million -1.3%N/A6.3 $4.90 12/15/20239,580,000 shares $46.65 million -8.7%N/A6 $4.87 11/30/202310,490,000 shares $45.95 million -6.6%N/A6.8 $4.38 11/15/202311,230,000 shares $48.06 million +4.6%N/A7.3 $4.28 10/31/202310,740,000 shares $47.69 million +8.5%N/A7.7 $4.44 10/15/20239,900,000 shares $42.42 million -6.9%N/A7.4 $4.29 9/30/202310,630,000 shares $57.93 million +7.6%N/A8.1 $5.45 9/15/20239,880,000 shares $59.87 million -5.1%N/A8.4 $6.06 8/31/202310,410,000 shares $70.48 million +3.5%N/A9.1 $6.77 8/15/202310,060,000 shares $63.28 million +5.3%N/A8.7 $6.29 7/31/20239,550,000 shares $80.60 million +6.4%N/A8.8 $8.44 7/15/20238,980,000 shares $64.39 million +12.1%N/A8.9 $7.17 6/30/20238,010,000 shares $53.75 million -0.9%5.8%7.9 $6.71 6/15/20238,080,000 shares $70.05 million +10.4%5.8%8.2 $8.67 5/31/20237,320,000 shares $50.95 million +10.4%5.3%8.2 $6.96 5/15/20236,630,000 shares $43.03 million +8.9%4.8%7.7 $6.49 4/30/20236,090,000 shares $43.48 million +12.2%4.4%6.7 $7.14 4/15/20235,430,000 shares $42.95 million -11.3%3.9%5.9 $7.91 3/31/20236,120,000 shares $54.04 million +14.8%4.4%6.4 $8.83 3/15/20235,330,000 shares $43.81 million +9.5%3.9%5.3 $8.22 2/28/20234,870,000 shares $41.64 million +9.4%3.5%4.9 $8.55Reality Check: Are You Prepared for What's Next? (Ad)Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ongoing market volatility add layers of unpredictability that complicate even the best-laid financial plans. It's easy to find yourself asking...What happens if the world doesn't return to "normal"? 2/15/20234,450,000 shares $44.63 million -6.3%3.2%4.4 $10.03 1/31/20234,750,000 shares $44.03 million -12.4%3.4%4.7 $9.27 1/15/20235,420,000 shares $53.87 million -8.3%3.9%5.2 $9.94 12/30/20225,910,000 shares $45.15 million +25.0%4.2%5.8 $7.64 12/15/20224,730,000 shares $38.45 million -11.1%3.4%4.7 $8.13 11/30/20225,320,000 shares $46.71 million +3.3%3.8%5.2 $8.78 11/15/20225,150,000 shares $46.81 million -13.9%3.7%4.9 $9.09 10/31/20225,980,000 shares $46.52 million -2.3%4.3%5.4 $7.78 10/15/20226,120,000 shares $38.31 million -5.1%4.4%5.4 $6.26 9/30/20226,450,000 shares $45.92 million +3.4%4.6%5.7 $7.12 9/15/20226,240,000 shares $52.67 million -9.4%4.5%4.4 $8.44 8/31/20226,890,000 shares $61.46 million +6.0%4.9%4.4 $8.92 8/15/20226,500,000 shares $82.36 million +1.3%4.7%3.9 $12.67 7/31/20226,420,000 shares $58.81 million -7.6%4.6%3.7 $9.16 7/15/20226,950,000 shares $66.23 million -7.6%5.0%3.9 $9.53 6/30/20227,520,000 shares $60.84 million +2.7%5.4%4.1 $8.09 6/15/20227,320,000 shares $52.34 million +15.5%5.3%4.2 $7.15 5/31/20226,340,000 shares $49.58 million -8.3%4.6%4.4 $7.82 5/15/20226,910,000 shares $56.94 million +32.4%5.0%4.8 $8.24 4/30/20225,220,000 shares $43.07 million -1.9%3.8%3.8 $8.25 4/15/20225,320,000 shares $57.56 million +11.5%3.8%4.1 $10.82 3/31/20224,770,000 shares $66.21 million -12.0%N/A3.8 $13.88 3/15/20225,420,000 shares $58.27 million -0.4%N/A4.5 $10.75 2/28/20225,440,000 shares $78.50 million -5.2%3.9%4.9 $14.43 2/15/20225,740,000 shares $84.32 million +10.0%4.1%5.1 $14.69 1/31/20225,220,000 shares $91.04 million +20.3%3.8%5.3 $17.44 1/15/20224,340,000 shares $83.98 million +14.2%3.1%5 $19.35 12/31/20213,800,000 shares $106.63 million -6.6%2.7%5.1 $28.06 12/15/20214,070,000 shares $111.03 million +8.8%2.9%5.9 $27.28 11/30/20213,740,000 shares $97.58 million -0.8%2.7%5.7 $26.09 11/15/20213,770,000 shares $122.83 million -10.9%2.7%6.3 $32.58 10/29/20214,230,000 shares $141.32 million -0.9%3.0%7.7 $33.41 10/15/20214,270,000 shares $143.05 million -3.2%3.1%8 $33.50 9/30/20214,410,000 shares $149.90 million +4.8%3.2%7.9 $33.99 9/15/20214,210,000 shares $154.13 million +5.3%3.0%7.1 $36.61 8/31/20214,000,000 shares $145.28 million -8.5%2.9%6.8 $36.32 8/13/20214,370,000 shares $138.97 million -8.0%3.2%7.1 $31.80 7/30/20214,750,000 shares $174.14 million +3.9%3.4%6.5 $36.66 7/15/20214,570,000 shares $161.00 million -2.1%3.3%5.8 $35.23 6/30/20214,670,000 shares $190.82 million +11.7%3.4%5.6 $40.86 6/15/20214,180,000 shares $160.43 million -4.1%3.0%4.7 $38.38 5/28/20214,360,000 shares $164.85 million -9.9%3.2%4.4 $37.81 5/14/20214,840,000 shares $162.72 million +1.3%N/A4.1 $33.62 4/30/20214,780,000 shares $204.78 million +9.4%N/A4.5 $42.84 4/15/20214,370,000 shares $186.12 million +1.6%N/A4.3 $42.59 3/31/20214,300,000 shares $161.59 million +12.9%N/A4.1 $37.58 3/15/20213,810,000 shares $158.08 million +10.1%N/A3.8 $41.49 2/26/20213,460,000 shares $191.37 million +14.6%N/A3.6 $55.31 2/12/20213,020,000 shares $194.40 million -4.7%N/A3.8 $64.37 1/29/20213,170,000 shares $181.01 million -26.3%N/A3.8 $57.10Reality Check: Are You Prepared for What's Next? (Ad)Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ongoing market volatility add layers of unpredictability that complicate even the best-laid financial plans. It's easy to find yourself asking...What happens if the world doesn't return to "normal"? 1/15/20214,300,000 shares $282.30 million -6.5%N/A5.2 $65.65 12/31/20204,600,000 shares $273.24 million +7.2%N/A5.8 $59.40 12/15/20204,290,000 shares $245.30 million +10.9%N/A5.1 $57.18 11/30/20203,870,000 shares $181.89 million -46.0%N/A4.5 $47.00 11/15/20207,170,000 shares $352.05 million +49.7%N/A8.3 $49.10 10/30/20204,790,000 shares $248.31 million +18.0%N/A5.7 $51.84 10/15/20204,060,000 shares $210.67 million -22.2%N/A4.6 $51.89 9/30/20205,220,000 shares $253.85 million +26.7%N/A4.9 $48.63 9/15/20204,120,000 shares $189.31 million +35.5%N/A3.9 $45.95 8/31/20203,040,000 shares $126.49 million +27.7%N/A3 $41.61 8/14/20202,380,000 shares $93.53 million +7.7%N/A2.1 $39.30 7/31/20202,210,000 shares $82.48 million -9.8%N/A1.9 $37.32 7/15/20202,450,000 shares $105.96 million -14.3%N/A2.1 $43.25 6/30/20202,860,000 shares $131.73 million +2.9%2.4%2.8 $46.06 6/15/20202,780,000 shares $123.65 million +0.7%2.3%2.7 $44.48 5/29/20202,760,000 shares $106.81 million +2.6%2.3%2.5 $38.70 5/15/20202,690,000 shares $91.65 million -16.2%2.3%2.4 $34.07 4/30/20203,210,000 shares $102.75 million +7.0%2.7%3 $32.01 4/15/20203,000,000 shares $85.29 million -2.6%2.5%2.3 $28.43 3/31/20203,080,000 shares $89.63 million -6.9%2.6%2.3 $29.10 3/13/20203,308,700 shares $85.27 million -10.3%N/A3.3 $25.77 2/28/20203,690,000 shares $83.62 million -1.6%N/A3 $22.66 2/14/20203,750,000 shares $93.64 million +4.2%3.2%3.3 $24.97 1/31/20203,600,000 shares $106.74 million -11.3%3.1%3.4 $29.65 1/15/20204,060,000 shares $127.69 million -18.3%3.5%4.1 $31.45 12/31/20194,970,000 shares $151.83 million +45.8%4.3%7.5 $30.55 ADPT Short Interest - Frequently Asked Questions What is Adaptive Biotechnologies' current short interest? Short interest is the volume of Adaptive Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 9,480,000 shares of ADPT short. Learn More on Adaptive Biotechnologies' current short interest. What is a good short interest ratio for Adaptive Biotechnologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADPT shares currently have a short interest ratio of 8.0. Learn More on Adaptive Biotechnologies's short interest ratio. Is Adaptive Biotechnologies' short interest increasing or decreasing? Adaptive Biotechnologies saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 9,480,000 shares, a decline of 4.3% from the previous total of 9,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adaptive Biotechnologies' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Adaptive Biotechnologies: Kodiak Sciences Inc. (2.94%), Guardant Health, Inc. (11.12%), Iovance Biotherapeutics, Inc. (24.42%), Kymera Therapeutics, Inc. (14.00%), Apogee Therapeutics, Inc. (18.90%), Twist Bioscience Co. (15.07%), CG Oncology, Inc. (14.81%), Scholar Rock Holding Co. (18.66%), SpringWorks Therapeutics, Inc. (17.19%), Vericel Co. (7.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Adaptive Biotechnologies stock? Short selling ADPT is an investing strategy that aims to generate trading profit from Adaptive Biotechnologies as its price is falling. ADPT shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adaptive Biotechnologies? A short squeeze for Adaptive Biotechnologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADPT, which in turn drives the price of the stock up even further. How often is Adaptive Biotechnologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADPT, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Kodiak Sciences Short Interest Data Guardant Health Short Interest Data Iovance Biotherapeutics Short Interest Data Kymera Therapeutics Short Interest Data Apogee Therapeutics Short Interest Data Twist Bioscience Short Interest Data CG Oncology Short Interest Data Scholar Rock Short Interest Data SpringWorks Therapeutics Short Interest Data Vericel Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADPT) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
